The one difference in this example, the one 800mg pill is less harsh on the stomach than taking 4 of the 200mg pills. Which is the reasoning usually for this type of prescription, that and convenience for the patient.
Insurance does not actually pay that much. Because of drug rebates (paid by the drug manufacturer), clawbacks, and Co-Pays, in total the drug manufacturer gets about the same as they would for the OTC drug.
See here: https://money.cnn.com/2018/05/07/news/economy/drug-prices-re... (and that article barely scratches the surface).
Destroying that entire money-network would be probably the #1 thing that could help US medical spending. And as much as people hate Trump, he's probably the only one with the actual ability, and desire to do something about it.
Other presidents have cared, but they were too risk adverse, Trump would be like "hmm, looks good - do it and let's see what happens". That kind of risk taking gets him in a lot of trouble, but it's why he was elected, and why he still has support despite the INCREDIBLY stupid things he says.
When I worked on doing data analytics for one of the large speciality pharmacies a while back, some of their medications had rebates in the low 5 figure range, the medications were typically a low 6 figure prescription. But for the generic meds they carried, there was no rebate and insurance paid the full fair at whatever was negotiated for the class of medications. That was a fun/educational project but also a bit depressing seeing how the system works. The pharmacies are also in this weird middle position where they have to process a lot of the data (and business rules), but can easily get squeezed out of the profit if they aren't savvy.
I am with you, destroying the supply chain money antics would be a huge benefit in the US to cutting down the waste and useless spending.
I'll believe he has either the ability or the desire when I see it.
The generic is $7.
This is OTC vs. Prescription.
Although I bet your insurance company doesn't actually pay $200 if they cover it - they probably get rebates that cover the difference, and then make you pay a higher co-pay.
They have - they are [often] the same ones who make the generic.
They make both, and if someone is willing to pay them extra for the brand name, they'll take it.
If the drug (or a similar in class competitor) is available OTC then they also can't charge as much via prescription.
So both ways, prices go down.